glp-1 drug delivery devices Delivering On Demand A Combination Of Device Offerings And Supply Strategy Navigating GLP-1 use in therapy
Description
has participated in the advisory boards and/or symposia for Inova and has received honoraria for this activity
21,25 A recent communication from the European Medicines Agency's Pharmacovigilance Risk Assessment Committee indicated that the current evidence does not support a causal link between GLP-1 RA and thyroid cancer, nor does it warrant alterations to the product information
Smith et al
GLP-1 is also an incretin hormone, enhancing insulin and suppressing glucagon secretion in the pancreas, thus lowering blood glucose
doi: 10.1038/s41419-020-03069-6 216 ClarkKLGeorgeJWPrzygrodzkaEPlewesMRHuaGWangCet al
Exercise benefits extend beyond improvements in liver outcomes, and have been shown to provide cardiovascular benefits, which is important as cardiovascular disease is a leading cause of death in this population
